INTEGRATE INTEGRATE - Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics
- Coordinator
- Academisch Ziekenhuis Groningen, Netherlands
- Runs
- 1 March 2026 to 28 February 2030
- Status
- Running
- EU funding
- €4.3m
- Total cost
- —
- Partners
- 34 organisations in 12 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101226862
What the project is doing
In the project's own words, from its summary on CORDIS.
Late-stage clinical trials show that psychedelic therapy (PT) has the potential to revolutionize mental disorder treatments, answering a huge and increasing unmet need. INTEGRATE is a multidisciplinary, multi-sectoral Doctoral Network (DN) for training and educating future leaders/experts in implementation of PT in society and healthcare. Four key challenges are identified: 1) The mechanisms of action of PT remain elusive, 2) Lack of clinical gold standards, 3) Legal, financial, and regulatory obstacles for PT access, and 4) Hype, hope, and ethical challenges.
Through interdisciplinary research, training, and collaboration, INTEGRATE aims to advance psychedelic science, optimize treatment protocols, and address ethical and regulatory challenges to improve mental healthcare. It addresses the urgent need for well-trained experts to navigate the complex landscape of PT in healthcare. The project will train 16 Doctoral Candidates (DCs) to become T-shaped professionals, equipped with deep disciplinary knowledge and broad interdisciplinary skills.
Through collaborative research, innovative training, and strategic secondments, INTEGRATE will tackle the key challenges in PT research with matching research and innovation objectives. The network brings together leading academic institutions, industry partners, and non-profit organizations across Europe, fostering a collaborative environment for advancing psychedelic science and improving mental healthcare.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Coordinator |
| Monash University | Victoria | Australia | Associatedpartner |
| Reconnect Labs AG | Winterthur | Switzerland | Associatedpartner |
| Schweizerische Ärztegesellschaft für Psycholytische Therapie (SÄPT) | Bern | Switzerland | Associatedpartner |
| Universitat Basel | Basel | Switzerland | Associatedpartner |
| Universitat Zurich | Zurich | Switzerland | Associatedpartner |
| Narodni Ustav Dusevniho Zdravi | Klecany | Czechia | Participant |
| Univerzita Karlova | Praha 1 | Czechia | Associatedpartner |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Associatedpartner |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Ethniko Kai Kapodistriako Panepistimio Athinon | Athina | Greece | Participant |
| Ecole Des Hautes Etudes En Sciences Sociales | Paris | France | Associatedpartner |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Universite Paris Cite | Paris | France | Associatedpartner |
| MIND Landelijke Platform Psychische Gezondheid | Amersfoort | Netherlands | Associatedpartner |
| Rijksuniversiteit Groningen | Groningen | Netherlands | Participant |
| Stichting Centre for Human Drug Research | Leiden | Netherlands | Associatedpartner |
| Stichting Open: Onderzoek Naar De Psychedelische Ervaring Nederland | Amsterdam | Netherlands | Associatedpartner |
| Universiteit Leiden | Leiden | Netherlands | Participant |
| Universiteit Maastricht | Maastricht | Netherlands | Associatedpartner |
| Avextra Portugal SA | Grândola | Portugal | Associatedpartner |
| Fundacao D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud | Lisboa | Portugal | Participant |
| Ispa Crl | Lisboa | Portugal | Associatedpartner |
| Osmond Labs AB | Uppsala | Sweden | Associatedpartner |
| Stockholms Universitet | Stockholm | Sweden | Participant |
| Svenska kyrkan Solna | Solna | Sweden | Associatedpartner |
| Uppsala Universitet | Uppsala | Sweden | Participant |
| Clerkenwell Clinics Limited | London | United Kingdom | Associatedpartner |
| Simon Geoffrey David Ruffell | Bristol | United Kingdom | Associatedpartner |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Associatedpartner |
| The University of Exeter | Exeter | United Kingdom | Associatedpartner |
| Alithos Health, Inc. | Newark, Delaware | United States | Associatedpartner |
| Johns Hopkins University | Baltimore | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI